Amended Statement of Ownership (sc 13g/a)
February 11 2020 - 4:15PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE
13G/A
Under
the Securities Exchange Act of 1934
(Amendment No. 1)*
BioSpecifics
Technologies Corp.
(Name
of Issuer)
Common Stock
(Title
of Class of Securities)
090931106
(CUSIP
Number)
Jeffrey K. Vogel,
1 Meadow Drive, Lawrence, NY 11559
(Name,
Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
12/31/2019
(Date
of Event which Requires Filing of this Statement)
Check the appropriate
box to designate the rule pursuant to which this Schedule is filed:
o Rule 13d-1(b)
x Rule 13d-1(c)
o Rule 13d-1(d)
*
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the
subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in
a prior cover page.
The information
required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall
be subject to all other provisions of the Act (however, see the Notes).
|
|
|
|
|
CUSIP No. 090931106
|
|
13G/A
|
|
Page 2 of 6 Pages
|
|
|
|
|
|
1.
|
|
NAMES
OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Jeffrey K. Vogel
|
|
|
2.
|
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)
(a) o
(b) o
|
|
|
3.
|
|
SEC
USE ONLY
|
|
|
4.
|
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
New York
|
|
|
|
|
|
|
|
NUMBER
OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
|
5.
|
|
SOLE
VOTING POWER
400,477
|
|
6.
|
|
SHARED
VOTING POWER
400,477
|
|
7.
|
|
SOLE
DISPOSITIVE POWER
400,477
|
|
8.
|
|
SHARED
DISPOSITIVE POWER
400,477
|
|
|
|
|
|
9.
|
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
400,477
|
|
|
10.
|
|
CHECK
IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(see instructions) o
|
|
|
11.
|
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.456 %
|
|
|
12.
|
|
TYPE
OF REPORTING PERSON (see instructions)
Individual
|
|
|
|
|
|
|
|
|
|
|
|
|
CUSIP No. 090931106
|
|
13G/A
|
|
Page 3 of 6
Pages
|
Item 1.
|
(a)
|
Name of Issuer
BioSpecifics Technologies Corp.
|
|
|
|
|
(b)
|
Address of Issuer’s Principal Executive
Offices
35 Wilbur Street, Lynbrook, NY 11563
|
|
|
|
Item 2.
|
(a)
|
Name of Person Filing
Jeffrey K. Vogel
|
|
|
|
|
(b)
|
Address of the Principal Office or, if
none, residence
1 Meadow Drive, Lawrence, NY 11559
|
|
|
|
|
(c)
|
Citizenship
USA
|
|
|
|
|
(d)
|
Title of Class of Securities
Common Stock
|
|
|
|
|
(e)
|
CUSIP Number
090931106
|
|
|
|
Item 3. If
this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
|
(a)
|
o
|
Broker or dealer registered
under section 15 of the Act (15 U.S.C. 78o).
|
|
|
|
|
|
(b)
|
o
|
Bank as defined in section 3(a)(6) of the
Act (15 U.S.C. 78c).
|
|
|
|
|
|
(c)
|
o
|
Insurance company as defined in section
3(a)(19) of the Act (15 U.S.C. 78c).
|
|
|
|
|
|
(d)
|
o
|
Investment company registered under section
8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
|
|
|
|
|
|
(e)
|
o
|
An investment adviser in accordance with
§240.13d-1(b)(1)(ii)(E);
|
|
|
|
|
|
(f)
|
o
|
An employee benefit plan or endowment fund
in accordance with §240.13d-1(b)(1)(ii)(F);
|
|
|
|
|
|
(g)
|
o
|
A parent holding company or control person
in accordance with §240.13d-1(b)(1)(ii)(G);
|
|
|
|
|
|
(h)
|
o
|
A savings associations as defined in Section
3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
|
|
|
|
|
(i)
|
o
|
A church plan that is excluded from the
definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
|
|
|
|
|
|
(j)
|
o
|
Group, in accordance with §240.13d-1(b)(1)(ii)(J).
|
|
|
|
|
|
CUSIP No. 090931106
|
|
13G/A
|
|
Page 4 of 6 Pages
|
Item 4. Ownership.
Provide the
following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item
1.
|
|
|
|
|
|
(a)
|
|
Amount beneficially owned: 400,477
|
|
|
|
|
|
|
(b)
|
|
Percent of class: 5.456
%
|
|
|
|
|
|
|
(c)
|
|
Number of shares as to which
the person has: 400,477
|
|
|
|
|
|
|
|
|
(i)
|
Sole power to vote or to direct the vote 400,477
|
|
|
|
|
|
|
|
|
(ii)
|
Shared power to vote or to direct the vote 400,477
|
|
|
|
|
|
|
|
|
(iii)
|
Sole power to dispose or to direct the
disposition of 400,477
|
|
|
|
|
|
|
|
|
(iv)
|
Shared power to dispose or to direct the
disposition of 400,477
|
|
|
|
|
|
Instruction.
For computations regarding securities which represent a right to acquire an underlying security see §240.13d-3(d)(1).
Item 5. Ownership
of Five Percent or Less of a Class.
If this statement
is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more
than five percent of the class of securities, check the following o.
Instruction.
Dissolution of a group requires a response to this item.
Item
6. Ownership of More than Five Percent on Behalf of Another Person.
Item 7. Identification
and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.
Item 8. Identification
and Classification of Members of the Group.
Item 9. Notice
of Dissolution of Group.
|
|
|
|
|
CUSIP No. 090931106
|
|
13G/A
|
|
Page 5 of 6 Pages
|
Item 10. Certification.
|
|
|
|
|
(a)
|
|
The following certification
shall be included if the statement is filed pursuant to §240.13d-1(b):
|
|
|
|
|
|
|
|
|
By signing below I certify that, to the
best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business
and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the
issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction
having that purpose or effect.
|
|
|
|
|
|
|
|
(b)
|
|
The following certification
shall be included if the statement is filed pursuant to §240.13d-1(c):
|
|
|
|
|
|
|
|
|
By signing below I certify that, to the
best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or
with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held
in connection with or as a participant in any transaction having that purpose or effect.
|
|
|
|
|
|
|
CUSIP No. 090931106
|
|
13G/A
|
|
Page 6 of 6 Pages
|
|
|
|
|
|
After
reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.
|
02/11/2020
|
|
Date
|
|
|
|
/s / Jeffrey K. Vogel
|
|
Signature
|
|
|
|
Jeffrey K. Vogel (individual)
|
|
Name/Title
|
BioSpecifics Technologies (NASDAQ:BSTC)
Historical Stock Chart
From Jul 2024 to Aug 2024
BioSpecifics Technologies (NASDAQ:BSTC)
Historical Stock Chart
From Aug 2023 to Aug 2024